Here’s what you should know:
1. The system includes the Abilify Mycite, the Mycite patch, the Mysite app and a web-based portal for providers.
2. Abilify Mycite tracks ingestion. The pill was designed to improve patient compliance. The sensor will transmit to the physician and user when the pill was taken.
3. Otsuka is rolling out the system in limited quantities so providers, health plans and the company can “[learn] from these patients’ experience.”
4. Otsuka will take the data from the limited rollout to enhance the system before launching a broader go-to-market plan.
Otsuka Pharmaceutical’s President Tatsuo Higuchi said in a release, “This approval marks a potentially transformative juncture in our more than 25 years of experience in the field of mental health therapies. We remain committed to making a difference for individual patients and their care team by helping address the challenge of objectively measuring medication ingestion.”
More articles on supply chain:
Common deficiencies AAAASF cites & how to fix them — continuing discussion on keeping up with documentation
‘Data is the crux of outpatient TJR’ — 2 physicians share strategies to build strong data platforms in ASCs
15 ASCs & outpatient facilities achieving accreditation — October 2017
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.